Access

News

Nature 432, 136 (11 November 2004) | doi:10.1038/432136b; Published online 10 November 2004

Hopes rise for RNA therapy as mouse study hits target

Erika Check

Top

Safety concerns eased for promising medical technique.

The efficacy of a promising therapeutic technique has been demonstrated in a study that might also relieve concerns about the approach's safety, researchers say.Biologists at the company Alnylam Pharmaceuticals this week publish results showing that RNA interference — RNAi, for short — can lower cholesterol levels in mice (see page 173).